Semnur Pharmaceuticals, Inc. Increase (Decrease) in Accrued Liabilities
Semnur Pharmaceuticals, Inc. (SMNR) reported Increase (Decrease) in Accrued Liabilities of $785.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-10
- Semnur Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $334.00K, a 70.91% decline year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $451.00K, a 162.21% increase year-over-year.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$527.00K.
- Semnur Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$89.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $785.00K 10-Q · filed 2026-08-10 | $258.00K derived: sum of 3 quarters · filed 2026-08-10 | $169.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $451.00K 10-Q · filed 2026-05-13 | -$76.00K derived: sum of 2 quarters · filed 2026-05-13 | -$165.00K derived: sum of 3 quarters · filed 2026-05-13 | $983.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$527.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | -$616.00K derived: sum of 2 quarters · filed 2026-05-12 | $532.00K derived: sum of 3 quarters · filed 2026-08-10 | $704.00K S-1 · filed 2026-05-12 |
| 2025-09-30 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.06M derived: sum of 2 quarters · filed 2026-08-10 | $1.23M 10-Q · filed 2025-11-12 | $458.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.32M 10-Q · filed 2026-08-10 | $547.00K derived: sum of 3 quarters · filed 2026-08-10 | |
| 2025-03-31 | $172.00K 10-Q · filed 2026-05-13 | -$601.00K derived: sum of 2 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$773.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-05-12 | -$861.00K S-1 · filed 2026-05-12 | ||
| 2024-09-30 | -$88.00K 10-Q · filed 2025-11-12 |